首页 › 基金 › ASO GROUP Ltd › SOLV

ASO GROUP Ltd 对 SOLV 的持仓历史

SOLVENTUM CORP · 医疗保健

ASO GROUP Ltd 在 Q3 2026 的 13F 申报中披露持有 SOLV(SOLVENTUM CORP)53,077 股,市值约 US$4.7M,约占其申报组合的 1.35%,在其申报持仓中市值排名第 14 位。 ASO GROUP Ltd 最近 4 个申报季度中有 4 个季度披露了 SOLV 持仓,最早可追溯至 Q4 2025。

最新持仓 (Q3 2026)53.08K 股
申报持仓市值$4.68M
组合权重1.35%
首次申报Q4 2025
最近变动减持
更新于2026-11-05

最后更新: 2026-11-05 · 来源: SEC EDGAR Form 13F-HR

ASO GROUP Ltd 对 SOLV 的持仓演变

ASO GROUP Ltd 于 Q4 2025 首次披露 SOLV 持仓:62,623 股(约 US$5.0M)。 在 4 次申报中,ASO GROUP Ltd 0 次增持、1 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 53,077 股、市值约 US$4.7M,环比减持 -9,546 股。。

逐季持仓明细

季度股数金额变化
Q4 2025 62.62K $4.96M 新进
Q1 2026 62.62K $4.09M 持有
Q2 2026 62.62K $4.83M 持有
Q3 2026 53.08K $4.68M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 SOLV 与 13F 数据

SOLV(SOLVENTUM CORP)属于医疗保健行业。我们追踪的基金中还有 45 只申报持有 SOLV,申报仓位最大的包括:Independent Franchise Partners LLP (US$1.25B), TRIAN FUND MANAGEMENT, L.P. (US$635.5M), DAVIS SELECTED ADVISERS (US$486.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 SOLV 的基金

查看 SOLV 的全部基金持有人 →

常见问题

How long has ASO GROUP Ltd held SOLV?

ASO GROUP Ltd has disclosed SOLV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is ASO GROUP Ltd's current position in SOLV?

As of Q3 2026, ASO GROUP Ltd holds 53.08K shares of SOLV (SOLVENTUM CORP), valued at $4.68M, representing 1.35% of its reported portfolio and ranking #14.

Has ASO GROUP Ltd been buying or selling SOLV?

In the latest 13F filing (Q3 2026), ASO GROUP Ltd reduced its position in SOLV.

Which other funds hold SOLV?

Other major institutional holders of SOLV include Independent Franchise Partners LLP, TRIAN FUND MANAGEMENT, L.P., DAVIS SELECTED ADVISERS, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.